Diamond-Blackfan Anemia

Familial Investigations of Childhood Cancer Predisposition

Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)

Investigation of the Genetics of Hematologic Diseases

CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation

T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias

Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies

Human Placental-Derived Stem Cell Transplantation

Multi-Center Study of Iron Overload: Pilot Study

Multi-Center Study of Iron Overload: Survey Study (MCSIO)

Stem Cell Transplant for Hemoglobinopathy

Bone Marrow Transplant With Abatacept for Non-Malignant Diseases

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs

Stem Cell Transplant for Bone Marrow Failure Syndromes

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders

Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation

Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias

Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells

Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload